Inventor · disambiguated record
G. Grant Welstead
Also filed as: WELSTEAD G GRANT
5 granted patents·12 pending applications·29 citations·filing 2008–2024
78Inventor score
Top patents by PatentIndex Score
17 records- 0189US10093904B2Reprogramming of somatic cellsWHITEHEAD INST BIOMEDICAL RES·Filed 2017·Granted Oct 9, 2018·8 cites·12 claims
- 0287US9382515B2Reprogramming of somatic cellsJAENISCH RUDOLF·Filed 2008·Granted Jul 5, 2016·12 cites·7 claims
- 0386US2025188423A1Reprogramming of somatic cellsWHITEHEAD INST BIOMEDICAL RES·Filed 2024·Application pending·0 cites
- 0485US9714414B2Reprogramming of somatic cellsWHITEHEAD INST BIOMEDICAL RES·Filed 2014·Granted Jul 25, 2017·7 cites·9 claims
- 0582US11242525B2CRISPR/CAS-related methods and compositions for treating sickle cell diseaseEDITAS MEDICINE INC·Filed 2015·Granted Feb 8, 2022·2 cites·28 claims
- 0675US2024294917A1Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)EDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 0768US2023026726A1Crispr/cas-related methods and compositions for treating sickle cell diseaseEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 0864US2022106600A1Crispr-cas-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 0962US2021380987A1Crispr/cas-related methods and compositions for treating cystic fibrosisEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 1060US2019241874A1Reprogramming of somatic cellsWHITEHEAD INST BIOMEDICAL RES·Filed 2018·Application pending·0 cites
- 1154US11028394B2CRISPR/CAS-related methods and compositions for treating cystic fibrosisEDITAS MEDICINE INC·Filed 2016·Granted Jun 8, 2021·0 cites·9 claims
- 1251US2023053028A1Engineered cells for therapyEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
- 1347US2017175128A1Crispr-cas-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2015·Application pending·0 cites
- 1446US2022184131A1Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methodsJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1541US2017007679A1Crispr/cas-related methods and compositions for treating hiv infection and aidsEDITAS MEDICINE INC·Filed 2016·Application pending·0 cites
- 1637US2019136230A1Genetically engineered cells and methods of making the sameJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1736US2018119123A1Crispr/cas-related methods and compositions for treating hiv infection and aidsEDITAS MEDICINE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when G. Grant Welstead files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →